News & Perspective

(CIDRAP News) – In releasing a new 5-year strategic plan yesterday, the federal agency tasked with developing new medical countermeasures (MCMs) for bioterrorist attacks and emerging diseases said many such products will be ready for regulatory review within the next 5 years.

(CIDRAP News) – Coming a month after federal officials released a blueprint for overhauling the nation's civilian biodefense program, the US Department of Health and Human Services (HHS) today announced the award of eight contracts worth up to $100 million to modernize and speed the development of countermeasures against natural and man-made disease threats.